The successful documentation and completion of clinical quality measurement requirements requires many interventions to take place within a practice. The following resource provides a summation of the key clinical interventions that can be used for cardiovascular quality improvement and includes the general data elements needed for measure calculation. This resource is intended for educational purposes only. Practices should work with their vendor to determine which CQMs their EHR system are certified to report on, and any specific workflow changes needed to ensure CQMs calculate properly in their specific EHR system.
The following information is presented in a series of tables:
For more information on the specific data elements required for clinical quality measures, visit the Meaningful Use portal in USHIK.
For further information on CQMs and Meaningful Use, please visit: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/index.html?redirect=/ehrincentiveprograms/
This table lists most of the Meaningful Use measures applicable to patients with cardiovascular conditions, with the associated National Quality Forum (NQF) number noted parenthetically.
Meaningful Use Cardiovascular Measures |
---|
Controlling High Blood Pressure (NQF# Not Applicable; CMS165v9) |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic (NQF# 0068; CMS164v7) |
Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (NQF# 0070e; CMS145v9) |
Pneumonia Vaccination for Older Adults (NQF# Not Applicable; CMS127v9) |
Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control (NQF# Not Applicable; CMS182v6) |
Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (NQF# 0081e; CMS135v9) |
Adult Weight Screening and Follow-up (NQF# Not Applicable; CMS69v9) |
Heart Failure: Beta Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) (NQF# 0083e; CMS144v9) |
Hypertension: improvement in blood pressure (NQF# Not Applicable; CMS65v8) |
ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range(NQF# Not Applicable; CMS179v5) |
Preventive Care and Screening: Cholesterol-Fasting Low Density Lipoprotein (LDL-C) Test Performed (NQF# Not Applicable; CMS61v6) |
Preventive Care and Screening: Risk-Stratified Cholesterol-Fasting Low Density Lipoprotein (LDL-C) Test Performed (NQF# Not Applicable; CMS64v6) |
This table lists key interventions to be completed during a patient’s visit. Documentation of these activities in the electronic health record will help ensure all of the necessary information needed to calculate Meaningful Use cardiovascular measures is available. For interventions that correlate to a specific cardiovascular measure, the applicable NQF number is noted parenthetically. Practices may find assigning responsibility for each of these activities to specific staff members helpful in integrating each activity into the practice workflow. Technical information regarding specific diagnoses and procedures associated with cardiovascular measures can be found in the Meaningful Use portal of USHIK.
This table specifies the information that needs to be documented in the electronic health record to appropriately calculate the numerator. The specific measure to which the element applies in noted by the NQF number in parentheses. Technical information related to the measure numerators can be found in the Meaningful Use portal of USHIK.
This table specifies the information that needs to be documented in the electronic health record to appropriately calculate the denominator. These elements apply to all Meaningful Use cardiovascular measures. Technical information related to the measure denominators can be found in the Meaningful Use portal of USHIK.
This table specifies the information that needs to be documented in the electronic health record to appropriately determine measure exclusions. These elements apply to all Meaningful Use cardiovascular measures. Technical information related to the measure exclusions/exceptions can be found in the Meaningful Use portal of USHIK.